EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine

Caroline Confais, Armel Houël, Louis-Marie Guignard, Jérome Abadie iD, Stéphane Dréano, Rémy Le Guevel iD, Rémy Pedeux iD, Aline Primot iD, Christophe Drieu La Rochelle, Catherine André, Ulrich Jarry iD, Benoit Hédan iD

Pigment Cell & Melanoma Research · 2026-11 · 39 (6)

DOI: 10.1111/pcmr.70131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 09.11.2026. Verfasst von Caroline Confais und 11 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, Rennes, France. Hauptthemen laut MEDLINE: Melanoma, Molecular Targeted Therapy, Mucous Membrane. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ligue Contre le Cancer, Agence Nationale de la Recherche, ANR-11-INBS-0003 Infrastructures en Biologie Santé et Agronomie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal melanoma (MM) is a rare and aggressive cancer in humans, with limited therapeutical options and no faithful models for preclinical research. Interestingly, this malignancy occurs spontaneously and with higher frequency in certain dog breeds, due to artificial selection contributing to predisposition to specific melanoma subtypes. Owing to the strong genetic and clinical similarities between canine and human cancers, the dog represents a powerful model in the context of comparative oncology. We genetically characterized a panel of 15 canine mucosal melanoma cell lines exploring the main mutations and copy number variants and showed that the main genetic alterations are the same as in human MM. We then evaluated the in vitro responses to anticancer agents and identified relevant correlations between genomic alterations and drug sensitivity. Idasanutlin, an MDM2 inhibitor, showed the most promising and specific responses across the panel, with sensitivity closely associated with TP53 mutational status. After validating tumorigenicity of each cell line, two of them, presenting contrasted sensitivities in vitro, demonstrated their respective resistant and sensitive profiles in in vivo murine xenografts. This work highlights the value of this canine mucosal melanoma cell lines panel, harboring different genetic alterations, recapitulating the main genetic alterations seen in human and canine MM. We thus provide here a relevant tool for preclinical drug testing, and we demonstrate the value of canine mucosal melanoma as a translational model for comparative oncology (see graphical abstract).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMolecular Targeted TherapyMucous MembraneAnimalsDogsHumansCell Line, TumorMutationAntineoplastic AgentsXenograft Model Antitumor AssaysDNA Copy Number VariationsDrug Evaluation, Preclinical

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, Rennes, France.
  • Biotrial Pharmacology, Unité de Pharmacologie Préclinique, Rennes, France.
  • LabOniris, Oniris VetAgroBio, Nantes, France.
  • Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Impaccell, Rennes, France.
  • Univ Rennes, INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Rennes, France.
  • Univ Rennes, CNRS, INSERM, BIOSIT UAR 3480, US_S 018, Oncotrial, Rennes, France.

ORCID-Profile: Jérome Abadie, Rémy Le Guevel, Rémy Pedeux, Aline Primot, Ulrich Jarry, Benoit Hédan

Förderung

  • Ligue Contre le Cancer
  • Agence Nationale de la Recherche
  • ANR-11-INBS-0003 Infrastructures en Biologie Santé et Agronomie

Zitieren

APA

Confais, C., Houël, A., Guignard, L. M., Abadie, J., Dréano, S., Le Guevel, R., Pedeux, R., Primot, A., La Rochelle, C. D., André, C., Jarry, U., & Hédan, B. (2026). Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine. Pigment Cell & Melanoma Research, 39(6). https://doi.org/10.1111/pcmr.70131

Vancouver

Confais C, Houël A, Guignard LM, Abadie J, Dréano S, Le Guevel R, et al. Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine. Pigment Cell & Melanoma Research. 2026;39(6). doi:10.1111/pcmr.70131

BibTeX
@article{Confais2026,
  author = {Confais, Caroline and Houël, Armel and Guignard, Louis-Marie and Abadie, Jérome and Dréano, Stéphane and Le Guevel, Rémy and Pedeux, Rémy and Primot, Aline and La Rochelle, Christophe Drieu and André, Catherine and Jarry, Ulrich and Hédan, Benoit},
  title = {Development of a Genetically Characterized Panel of 15 Mucosal Melanoma Cell Lines for the Preclinical Evaluation of Targeted Therapies in Human and Veterinary Medicine},
  journal = {Pigment Cell & Melanoma Research},
  year = {2026},
  volume = {39},
  number = {6},
  doi = {10.1111/pcmr.70131}
}
Kostenlos starten →